| | |
C.H. Unnikrishnan 12:46 AM | November 27,2009
Siemens Healthcare Diagnostics is a subsidiary of Siemens group company, Siemens Diagnostics Holdings of Netherlands
|
|
C.H. Unnikrishnan 12:03 AM | November 19,2009
The Mumbai-based pharmaceutical and biotechnology firm, India’s sixth largest by sales, told the stock exchanges that it is increasing its authorized capital from Rs175 crore to Rs925 crore
|
|
C.H. Unnikrishnan 11:50 PM | November 17,2009
Pfizer’s top executives are scheduled to visit Mumbai for talks, but Wockhardt says it’s in no hurry to sell assets
|
|
C.H. Unnikrishnan 08:49 PM | November 16,2009
The firm will receive $5 mn from Medicis for developing a treatment for acne; to get royalty if product reaches market
|
|
C.H. Unnikrishnan 08:41 PM | November 12,2009
In the past half a decade, big pharmaceutical firms haven’t developed any new blockbuster drugs, the lifeblood for them
|
|
C.H. Unnikrishnan and Reuters 10:56 PM | November 11,2009
The drug maker has offered to supply its A/H1N1 influenza drug, to the US
|
|
C.H. Unnikrishnan 09:39 PM | November 04,2009
The new rule allows a maximum life period of between one and five years for different Ayurveda, Siddha and Unani medicines
|
|
C.H. Unnikrishnan 10:39 PM | November 03,2009
The industry will be paid for the performance of the product and not just for the product, Friend says
|
|
C.H. Unnikrishnan 11:39 PM | October 30,2009
The company’s sales during the period grew 12% at Rs522.68 crore compared with Rs478.84 crore
|
|
C.H. Unnikrishnan 12:16 AM | October 30,2009
Small growth in sales, increased raw material and interest costs, and pricing pressure on some of its key products in the US led to the decline
|
|
C.H. Unnikrishnan 11:31 PM | October 28,2009
Aventis Pharma, an India-listed unit of French drug maker Sanofi-Aventis SA, is locked in a tussle over the vaccine with Novartis Healthcare Ltd, the Indian subsidiary of Switzerland’s Novartis AG
|
|
C.H. Unnikrishnan 11:04 PM | October 28,2009
The US drug regulator earlier this year seized all inventories at Caraco’s Michigan plant after it failed to comply with manufacturing quality norms
|
|
C.H. Unnikrishnan 02:17 AM | October 27,2009
US and Europe sales, accounting for almost a third of Lupin’s revenue, rose 28% to Rs3.53 billion in the quarter
|
|
C.H. Unnikrishnan 10:57 PM | October 26,2009
Pfizer Inc., the world’s largest drug maker, bought Wyeth in January in a $68 billion (around Rs3.2 trillion) global deal
|
|
C.H. Unnikrishnan 12:19 AM | October 23,2009
It posted a 44.8% rise in net profit to Rs100 crore in the September quarter
|
|